Cambridge Investment Research Advisors, Inc. Night Hawk Biosciences, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.4 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$0.77 - $1.62 $1,704 - $3,586
-2,214 Reduced 9.77%
20,442 $16,000
Q3 2022

Oct 17, 2022
SELL
$1.79 - $2.96 $1,406 - $2,326
-786 Reduced 3.35%
22,656 $0
Q4 2021

Feb 03, 2022
SELL
$3.04 - $6.01 $55,024 - $108,781
-18,100 Reduced 43.57%
23,442 $71,000
Q2 2021

Aug 10, 2021
BUY
$5.78 - $9.6 $34,680 - $57,600
6,000 Added 16.88%
41,542 $279,000
Q1 2021

May 07, 2021
BUY
$5.67 - $12.54 $201,523 - $445,696
35,542 New
35,542 $258,000

Others Institutions Holding NHWK

# of Institutions
5
Shares Held
48.5K
Call Options Held
0
Put Options Held
0
View Full List

About NightHawk Biosciences, Inc.

NHWK Quotes by TradingView
  • Ticker NHWK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,661,500
  • Market Cap $4.11M
  • Description
  • NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...
More about NHWK
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email